A signal peptide derived from Hsp60 induces protective cytotoxic T lymphocyte immunity against lymphoid malignancies independently of TAP and classical MHC-I-Reference-Cited by-同舟云学术

A signal peptide derived from Hsp60 induces protective cytotoxic T lymphocyte immunity against lymphoid malignancies independently of TAP and classical MHC-I

Published:2020-12 Issue: Volume:494 Page:47-57
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Chen Xun-Rui^ORCID,Yuan Hai-Hua,Guo Jia-Hui,Zhang Wen-Ying,Li Qian-Qian,Huang Guo-Ding,Zhang Yan-Jie,Jiang Bin,Liu Feng^ORCID

Funder

National Natural Science Foundation of China

Health Commission Foundation of Hainan Province

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference70 articles.

1. Signal sequences: more than just greasy peptides;Martoglio;Trends Cell Biol.,1998

2. The use of signal peptide domains as vaccine candidates;Kovjazin;Hum Vaccines Immunother.,2014

3. Signal peptides and trans-membrane regions are broadly immunogenic and have high CD8+ T cell epitope densities: implications for vaccine development;Kovjazin;Mol Immunol.,2011

4. Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathway;El Hage;Proc Natl Acad Sci USA.,2008

5. Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours;Durgeau;Nat Commun.,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is HLA-E with its receptors an immune checkpoint or an antigenic determinant in allo-HCT?;Best Practice & Research Clinical Haematology;2024-06

2. Cryptic MHC-E epitope from influenza elicits a potent cytolytic T cell response;Nature Immunology;2023-10-12

3. The Parallel Presentation of Two Functional CTL Epitopes Derived from the O and Asia 1 Serotypes of Foot-and-Mouth Disease Virus and Swine SLA-2*HB01: Implications for Universal Vaccine Development;Cells;2022-12-12